Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.
Cannabinoids have been reported to alter the activities of immune cells in vitro and in vivo. These compounds may serve as ideal agents for adjunct treatment of pathological processes that have a neuroinflammatory component. As highly lipophilic molecules, they readily access the brain. Furthermore, they have relatively low toxicity and can be engineered to selectively target cannabinoid receptors. To date, two cannabinoid receptors have been identified, characterized and designated CB(1) and CB(2). CB(1) appears to be constitutively expressed within the CNS while CB(2) apparently is induced during inflammation. The inducible nature of expression of CB(2) extends to microglia, the resident macrophages of the brain that play a critical role during early stages of inflammation in that compartment. Thus, the cannabinoid-cannabinoid receptor system may prove therapeutically manageable in ablating neuropathogenic disorders such as Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, HIV encephalitis, closed head injury, and granulomatous amebic encephalitis.
Cabral
G A
GA
Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, 1101 E. Marshall Street, Richmond, Virginia 23298-0678 USA. gacabral@vcu.edu
Griffin-Thomas
L
L
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism / Q000502:physiology; D002186:Cannabinoids / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007249:Inflammation / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000188:drug therapy*; D043882:Receptors, Cannabinoid / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects
D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D043882:Receptors, Cannabinoid
Science. 1992 Mar 6;255(5049):1246-9
1546323
Neurosci Lett. 2007 Jan 29;412(2):114-7
17123706
Clin Microbiol Rev. 2003 Apr;16(2):273-307
12692099
J Neurosci. 2003 Mar 15;23(6):2371-82
12657697
Pediatr Res. 2006 Aug;60(2):169-73
16864698
Nat Med. 2007 Apr;13(4):492-7
17401376
Glia. 2000 Jan 1;29(1):58-69
10594923
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8658-62
8378344
Toxicol Appl Pharmacol. 2005 Jun 1;205(2):107-15
15893538
J Neurosci. 2007 Feb 28;27(9):2396-402
17329437
Immunopharmacology. 1998 Nov;40(3):179-85
9858061
J Immunol. 1998 May 15;160(10):4671-80
9590212
J Neurosci. 1986 Aug;6(8):2163-78
3018187
J Med Primatol. 1992 Feb-May;21(2-3):59-63
1359149
Biochem Pharmacol. 2006 Sep 28;72(7):869-80
16914119
Clin Diagn Lab Immunol. 2002 May;9(3):515-24
11986254
Br J Pharmacol. 2003 Dec;140(8):1351-62
14645143
Lab Invest. 1991 Feb;64(2):135-56
1997729
FEBS Lett. 1995 Nov 13;375(1-2):143-7
7498464
J Neuroimmunol. 2004 Feb;147(1-2):127-30
14741443
Eur J Neurosci. 2004 Nov;20(9):2267-75
15525268
BMC Neurol. 2006 Mar 02;6:12
16512913
J Am Chem Soc. 1971 Jan 13;93(1):217-24
5538858
J Cell Biol. 2003 Nov 10;163(3):463-8
14610053
Neurobiol Dis. 2005 Nov;20(2):207-17
16242629
Am J Pathol. 1991 Sep;139(3):609-21
1716047
Biochem J. 1991 Oct 1;279 ( Pt 1):129-34
1718258
Trends Cell Biol. 1998 Nov;8(11):425-7
9854307
Br J Pharmacol. 2003 Jun;139(4):775-86
12813001
FASEB J. 2006 May;20(7):1003-5
16571781
Trends Neurosci. 1996 Aug;19(8):312-8
8843599
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
10570211
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
2308954
Neurobiol Dis. 2006 May;22(2):257-64
16364651
Nature. 1996 Nov 7;384(6604):83-7
8900284
Life Sci. 2006 Jan 2;78(6):549-63
16109430
Mol Pharmacol. 1988 Nov;34(5):605-13
2848184
Adv Exp Med Biol. 2001;493:207-14
11727767
Brain Res Brain Res Rev. 1995 Mar;20(3):269-87
7550361
J Toxicol Environ Health. 1991 Apr;32(4):465-77
1850002
Eur J Pharmacol. 2000 May 19;396(2-3):141-9
10822068
Brain Pathol. 2001 Jan;11(1):1-11
11145195
Trends Pharmacol Sci. 2007 Jan;28(1):39-45
17141334
J Neurochem. 2007 Apr;101(1):87-98
17241118
Nature. 1994 Jan 13;367(6459):188-93
8114918
Arzneimittelforschung. 1995 Mar;45(3A):357-60
7763326
No To Shinkei. 1992 Feb;44(2):95-102
1373637
J Neurosci Res. 2002 Mar 15;67(6):829-36
11891798
Trends Neurosci. 1988 Jun;11(6):273-7
2465626
Nature. 1997 Aug 21;388(6644):773-8
9285589
Science. 1985 Oct 4;230(4721):71-3
2412295
Int Rev Cytol. 1997;171:167-224
9066128
FEBS Lett. 1998 Jan 23;422(1):69-73
9475172
Mol Pharmacol. 1995 Aug;48(2):352-61
7651369
J Clin Invest. 2003 Apr;111(8):1231-40
12697742
Mol Pharmacol. 1984 Nov;26(3):532-8
6092901
Mt Sinai J Med. 1993 Sep;60(4):271-8
8232369
Toxicol Appl Pharmacol. 1997 Feb;142(2):278-87
9070350
Proc Soc Exp Biol Med. 1995 Oct;210(1):64-76
7675800
Eur J Biochem. 1995 Aug 15;232(1):54-61
7556170
Glia. 1992;6(1):39-47
1380949
Biochem J. 1995 Dec 1;312 ( Pt 2):637-41
8526880
Int Immunopharmacol. 2002 Jan;2(1):69-82
11789671
Chem Phys Lipids. 2000 Nov;108(1-2):53-70
11106782
J Neuroimmunol. 1997 Feb;72(2):169-77
9042110
DNA Seq. 1995;5(6):385-8
8777318
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S21-6
9330981
FEBS Lett. 1998 Aug 14;433(1-2):139-42
9738948
J Neurosci. 2005 Mar 9;25(10):2530-6
15758162
Nature. 1993 Sep 2;365(6441):61-5
7689702
J Biol Chem. 2004 Feb 13;279(7):5298-305
14634025
J Neuroimmunol. 2006 Dec;181(1-2):82-92
17045344
Mol Pharmacol. 1986 Mar;29(3):307-13
2869405
Neuroscience. 1994 Dec;63(3):637-52
7898667
FEBS Lett. 2005 Nov 21;579(28):6473-8
16288744
Mol Immunol. 2006 Jul;43(14):2169-79
16503355
J Neurosci. 2003 Dec 3;23(35):11136-41
14657172
Handb Exp Pharmacol. 2005;(168):385-423
16596782
J Virol. 1994 Nov;68(11):7099-107
7933091
Biochem Pharmacol. 1995 Jun 29;50(1):83-90
7605349
Nature. 2001 Oct 4;413(6855):527-31
11586361
Neurol Res. 1995 Aug;17(4):275-80
7477742
J Neurochem. 2004 Jun;89(6):1555-7
15189359
Science. 1992 Dec 18;258(5090):1946-9
1470919
Mol Pharmacol. 2001 Jul;60(1):155-63
11408610
Immunol Today. 1998 Aug;19(8):373-81
9709506
Glia. 2005 Jan 15;49(2):211-9
15390091
J Neuroinflammation. 2005 Dec 12;2:29
16343349
Adv Neuroimmunol. 1994;4(3):257-60
7874392
FASEB J. 1991 Jul;5(10):2391-7
2065887
J Neurotrauma. 1993 Summer;10(2):109-19
8411215
Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408
11316486
J Mol Med (Berl). 1997 Mar;75(3):165-73
9106073
Eur J Biochem. 1996 Aug 15;240(1):53-62
8797835
Neuroreport. 1997 May 27;8(8):1929-33
9223079
Res Virol. 1996 Mar-Jun;147(2-3):79-88
8901425
Brain. 2003 Oct;126(Pt 10):2191-202
12876144
Brain Res. 2006 Aug 30;1107(1):199-205
16822488
J Neuroimmunol. 2006 Dec;181(1-2):57-67
17011047
J Pharmacol Sci. 2004 Dec;96(4):362-6
15599103
J Neurosci. 2005 Feb 23;25(8):1904-13
15728830
J Pharmacol Exp Ther. 2000 Mar;292(3):886-94
10688601
Synapse. 2004 Sep 15;53(4):208-13
15266552
Chem Phys Lipids. 2002 Dec 31;121(1-2):57-63
12505690
Biochem Biophys Res Commun. 1996 Jan 5;218(1):113-7
8573114
J Neurochem. 2005 Oct;95(2):437-45
16086683
Glia. 1993 Jan;7(1):9-18
8423067
FASEB J. 2005 Aug;19(10):1338-40
15941768
Mol Cell Neurosci. 2007 Apr;34(4):551-61
17229577
Br J Pharmacol. 2007 Nov;152(5):624-32
17704819
Eur J Pharmacol. 2006 Aug 7;542(1-3):100-5
16781706
Biochim Biophys Acta. 1996 Jun 7;1307(2):132-6
8679694
Crit Care Med. 2002 Mar;30(3):548-54
11990913
J Neurosci. 1997 Feb 15;17(4):1226-42
9006968
Eur J Neurosci. 2006 Mar;23(6):1530-8
16553616
J Leukoc Biol. 2003 Oct;74(4):486-96
12960289
Trends Cell Biol. 1998 Nov;8(11):447-53
9854312
J Pharmacol Exp Ther. 1999 Jun;289(3):1620-5
10336560
Biochem J. 1998 Apr 1;331 ( Pt 1):15-9
9512456
J Pharmacol Exp Ther. 1998 Feb;284(2):644-50
9454810
FASEB J. 2000 Jul;14(10):1432-8
10877836
Biochem Pharmacol. 1996 Sep 13;52(5):743-51
8765472
Neurobiol Aging. 1988 Jul-Aug;9(4):339-49
3263583
Mol Pharmacol. 1985 Apr;27(4):429-36
2984538
J Neuroimmunol. 1998 Feb;82(1):13-21
9526841
J Neurochem. 2000 Dec;75(6):2434-44
11080195
Int J Immunopharmacol. 1992 Nov;14(8):1445-52
1334476
J Neurosci. 2003 Apr 1;23(7):2511-6
12684434
Brain Res. 1995 Jul 10;685(1-2):1-11
7583233
J Pharmacol Exp Ther. 1993 Dec;267(3):1558-65
8263818
Eur J Biochem. 1996 May 1;237(3):704-11
8647116
Biochem Pharmacol. 2006 Dec 15;72(12):1697-706
17007821
Mult Scler. 2004 Apr;10(2):158-64
15124761
Neuroscience. 2007 Feb 23;144(4):1516-22
17178196
Glia. 1988;1(5):301-7
2976393
Annu Rev Microbiol. 1992;46:655-93
1444270
Neuroscience. 2005;134(1):261-8
15953683
Dev Neurosci. 1993;15(6):423-32
7835248
J Neurosci. 2003 Feb 15;23(4):1398-405
12598628
Ann N Y Acad Sci. 1988;540:319-23
3061340
J Neuroimmunol. 2000 Sep 22;109(2):155-63
10996217
J Leukoc Biol. 2005 Dec;78(6):1192-7
16204639
J Leukoc Biol. 1999 Apr;65(4):466-74
10204575
Glia. 2003 Jan 15;41(2):161-8
12509806
J Neuroimmune Pharmacol. 2008 Jun;3(2):117-29
18247131
Neuron. 2006 Jan 5;49(1):67-79
16387640
Eur J Pharmacol. 2003 Aug 8;474(2-3):195-8
12921861
J Neurosci. 2003 Jul 23;23(16):6470-4
12878687
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):182-4
16183560
Nature. 1990 Aug 9;346(6284):561-4
2165569
Br J Pharmacol. 2007 Feb;150(4):519-25
17220914